Alan F Holmer - Net Worth and Insider Trading
Alan F Holmer Net Worth
The estimated net worth of Alan F Holmer is at least $13,890 dollars as of 2024-11-07. Alan F Holmer is the Director of Corbus Pharmaceuticals Holdings Inc and owns about 750 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) stock worth over $13,890. Details can be seen in Alan F Holmer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan F Holmer has not made any transactions after 2017-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alan F Holmer
Alan F Holmer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan F Holmer owns 1 companies in total, including Corbus Pharmaceuticals Holdings Inc (CRBP) .
Click here to see the complete history of Alan F Holmer’s form 4 insider trades.
Insider Ownership Summary of Alan F Holmer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2017-05-11 | director |
Alan F Holmer Latest Holdings Summary
Alan F Holmer currently owns a total of 1 stock. Alan F Holmer owns 750 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) as of May 11, 2017, with a value of $13,890.
Latest Holdings of Alan F Holmer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2017-05-11 | 750 | 18.52 | 13,890 |
Holding Weightings of Alan F Holmer
Alan F Holmer Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan F Holmer has made a total of 0 transactions in Corbus Pharmaceuticals Holdings Inc (CRBP) over the past 5 years. The most-recent trade in Corbus Pharmaceuticals Holdings Inc is the acquisition of 17 shares on May 11, 2017, which cost Alan F Holmer around $3,115.
Insider Trading History of Alan F Holmer
- 1
Alan F Holmer Trading Performance
GuruFocus tracks the stock performance after each of Alan F Holmer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan F Holmer is -0.51%. GuruFocus also compares Alan F Holmer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan F Holmer within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alan F Holmer's insider trading performs compared to the benchmark.
Performance of Alan F Holmer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.01 | | | | | |
| Relative Return to S&P 500(%) | 3.39 | | | | | |
Alan F Holmer Ownership Network
Ownership Network List of Alan F Holmer
Ownership Network Relation of Alan F Holmer
Alan F Holmer Owned Company Details
What does Corbus Pharmaceuticals Holdings Inc do?
Who are the key executives at Corbus Pharmaceuticals Holdings Inc?
Alan F Holmer is the director of Corbus Pharmaceuticals Holdings Inc. Other key executives at Corbus Pharmaceuticals Holdings Inc include Chief Financial Officer Sean F. Moran , director & Chief Executive Officer Yuval Cohen , and Chief Commercial Officer Craig Stuart Millian .
Corbus Pharmaceuticals Holdings Inc (CRBP) Insider Trades Summary
Over the past 18 months, Alan F Holmer made no insider transaction in Corbus Pharmaceuticals Holdings Inc (CRBP). Other recent insider transactions involving Corbus Pharmaceuticals Holdings Inc (CRBP) include a net purchase of 1,032,632 shares made by Cormorant Global Healthcare Master Fund, Lp , a net purchase of 900,000 shares made by Cormorant Asset Management, Lp , and a net sale of 63,358 shares made by Yuval Cohen .
In summary, during the past 3 months, insiders sold 0 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) in total and bought 350,000 shares, with a net purchase of 350,000 shares. During the past 18 months, 81,401 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) were sold and 1,932,632 shares were bought by its insiders, resulting in a net purchase of 1,851,231 shares.
Corbus Pharmaceuticals Holdings Inc (CRBP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corbus Pharmaceuticals Holdings Inc Insider Transactions
Alan F Holmer Mailing Address
Above is the net worth, insider trading, and ownership report for Alan F Holmer. You might contact Alan F Holmer via mailing address: C/o Corbus Pharmaceuticals Holdings, Inc, 100 River Ridge Drive, Norwood Ma 02062.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
